Spectral Medical Stock Forecast for 2023 - 2025 - 2030

Updated on 05/03/2024

Stock Rating
0
Price Target
C$1.80
Consensus
Outperform
Upside
300.00%
Analysts
0
Stock Rating
0
Upside
300.00%
Analysts
0
Price Target
C$1.80

Spectral Medical Stock Forecast and Price Target

The average price target for Spectral Medical's stock lately set by several renowned analysts is C$1.80, which would result in a potential upside of approximately 300% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of C$1.80 and a low estimate of C$1.80. Even if you are not interested in EDT stock, you should still be aware of its competitors.

C$1.80

300.00% Upside

Buy
Buy

Spectral Medical Fair Value Forecast for 2023 - 2025 - 2030

Spectral Medical's Price has seen growth In the last year, going from C$0.00 to C$0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach C$0.48 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.

2024 Fair Value Forecast
C$0.48
2025 Fair Value Forecast
C$0.52
2026 Fair Value Forecast
C$0.57
2027 Fair Value Forecast
C$0.62
2028 Fair Value Forecast
C$0.68
2029 Fair Value Forecast
C$0.75
2030 Fair Value Forecast
C$0.82

Spectral Medical Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Spectral Medical's Revenue has fallen from C$2.10M to C$1.67M – a 20.48% decrease. In the next year, analysts believe that Revenue will reach C$1.94M – an increase of 15.98%. For the next eight years, the forecast is forRevenue to grow by 17.48%.

2023 Rev Forecast
C$0.00B
2024 Rev Forecast
C$0.00B
2025 Rev Forecast
C$0.00B
2026 Rev Forecast
C$0.00B
2027 Rev Forecast
C$0.00B
2028 Rev Forecast
C$0.00B
2029 Rev Forecast
C$0.00B
2030 Rev Forecast
C$0.00B

Spectral Medical Dividend per Share Forecast for 2023 - 2025 - 2030

Spectral Medical Free Cash Flow Forecast for 2023 - 2025 - 2030

Spectral Medical EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Spectral Medical's EBITDA has gone down from C$-8.34M to C$-7.70M – a 7.67% drop. In the next year, 1 analysts estimate that Spectral Medical's EBITDA will decrease by 3.90%, reaching C$-7.40M. According to professional forecasts, in 2030, Spectral Medical's EBITDA will decrease by 24.03%, reaching C$-5.85M.

2024 EBITDA Forecast
C$-7400000.00
2025 EBITDA Forecast
C$-3900000.00
2026 EBITDA Forecast
C$-5264480.00
2027 EBITDA Forecast
C$-6455480.86
2028 EBITDA Forecast
C$-7431764.75
2029 EBITDA Forecast
C$-6007095.45
2030 EBITDA Forecast
C$-5849509.31

Spectral Medical EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Spectral Medical's EBIT has fallen from C$-8.55M to C$-7.88M – a 7.84% decrease. For next year, the 0 analysts predict EBIT of C$-8.40M, which would mean an increase of 6.65%. Over the next eight years, the pros' prediction is EBITof C$-8.43M, which would mean a eight-year growth forecast of 6.96%.

2023 EBIT Forecast
C$-8403757.33
2024 EBIT Forecast
C$-8474909.15
2025 EBIT Forecast
C$-8590732.90
2026 EBIT Forecast
C$-8349619.67
2027 EBIT Forecast
C$-8369102.11
2028 EBIT Forecast
C$-8405647.19
2029 EBIT Forecast
C$-8468129.17
2030 EBIT Forecast
C$-8428611.23

Spectral Medical EPS Price Prediction Forecast for 2023 - 2025 - 2030

Spectral Medical's EPS has seen growth In the last year, going from C$-0.04 to C$0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach C$-0.03 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.

2024 EPS Forecast
C$-0.03
2025 EPS Forecast
C$-0.02
2026 EPS Forecast
C$-0.02
2027 EPS Forecast
C$-0.02
2028 EPS Forecast
C$-0.02
2029 EPS Forecast
C$-0.02
2030 EPS Forecast
C$-0.02